Your new post is loading...
Research and publish the best content.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Already have an account: Login
Bioscience News - GEG Tech top picks
8.8K views |
+2 today
Lexington, Mass.-based Homology Medicines launched today with a $43.5 million Series A preferred stock financing.
Homology Medicines will focus on a new gene editing technology, which the founders claim are a better version of CRISPR-Cas9. None of the company’s work has been published, although one of the company’s investors indicates it will publish findings soon.